{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:56:49Z","timestamp":1793332609297,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    GPNMB is involved in multiple cellular functions including cell adhesion, stress protection and stem cell maintenance. In skin, melanocyte-GPNMB is suggested to mediate pigmentation through melanosome formation, but details of keratinocyte-GPNMB have yet to be well understood. We confirmed the expression of GPNMB in normal human epidermal keratinocytes (NHEKs) by reducing the expression using siRNA. A higher calcium concentration of over 1.25\u2009mM decreased the GPNMB expression. Histological staining showed that GPNMB was expressed in the basal layer of normal skins but completely absent in vitiligo skins. The normal expression of GPNMB in nevus depigmentosus skin suggested that lack of GPNMB is characteristic of vitiligo lesional skins. IFN-\u03b3 and IL-17A, two cytokines with possible causal roles in vitiligo development, inhibited GPNMB expression\n                    <jats:italic>in vitro<\/jats:italic>\n                    . Approximately 4\u20138% of the total GPNMB expressed on NHEKs were released possibly by ADAM 10 as a soluble form, but the process of release was not affected by the cytokines. The suppressive effect of IFN-\u03b3 on GPNMB was partially via IFN-\u03b3\/JAK2\/STAT1 signaling axis. Decreased GPNMB expression in keratinocytes may affect melanocyte maintenance or survival against oxidative stress although further studies are needed. These findings indicate a new target for vitiligo treatment, focusing on the novel role of IFN-\u03b3 and IL-17 in downregulating keratinocyte-GPNMB.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-61931-1","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T08:46:08Z","timestamp":1584521168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["GPNMB is expressed in human epidermal keratinocytes but disappears in the vitiligo lesional skin"],"prefix":"10.1038","volume":"10","author":[{"given":"Kazal Boron","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Ishitsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunasiri","family":"Iddamalgoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"key":"61931_CR1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1600-0625.2008.00830.x","volume":"18","author":"M Tomihari","year":"2009","unstructured":"Tomihari, M., Hwang, S. H., Chung, J. S., Cruz, P. D. Jr. & Ariizumi, K. Gpnmb is a melanosome-associated glycoprotein that contributes to melanocyte\/keratinocyte adhesion in a RGD-dependent fashion. Exp. Dermatol. 18, 586\u2013595 (2009).","journal-title":"Exp. Dermatol."},{"key":"61931_CR2","first-page":"839","volume":"6","author":"G Maric","year":"2013","unstructured":"Maric, G., Rose, A. A., Annis, M. G. & Siegel, P. M. Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer. Onco. Targets. Ther. 6, 839\u2013852 (2013).","journal-title":"Onco. Targets. Ther."},{"key":"61931_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/jcb.1259","volume":"84","author":"FF Safadi","year":"2001","unstructured":"Safadi, F. F. et al. Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts. J. Cell. Biochem. 84, 12\u201326 (2001).","journal-title":"J. Cell. Biochem."},{"key":"61931_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/brb3.39","volume":"2","author":"JJ Huang","year":"2012","unstructured":"Huang, J. J., Ma, W. J. & Yokoyama, S. Expression and immunolocalization of Gpnmb, a glioma-associated glycoprotein, in normal and inflamed central nervous systems of adult rats. Brain Behav. 2, 85\u201396 (2012).","journal-title":"Brain Behav."},{"key":"61931_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jhep.2004.12.021","volume":"42","author":"B Haralanova-Ilieva","year":"2005","unstructured":"Haralanova-Ilieva, B., Ramadori, G. & Armbrust, T. Expression of osteoactivin in rat and human liver and isolated rat liver cells. J. Hepatol. 42, 465\u2013572 (2005).","journal-title":"J. Hepatol."},{"key":"61931_CR6","doi-asserted-by":"publisher","first-page":"C697","DOI":"10.1152\/ajpcell.00565.2004","volume":"289","author":"T Ogawa","year":"2005","unstructured":"Ogawa, T. et al. Osteoactivin upregulates expression of MMP-3 and MMP-9 in fibroblasts infiltrated into denervated skeletal muscle in mice. Am. J. Physiol. Cell. Physiol. 289, C697\u2013C707 (2005).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"61931_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00262-011-1096-1","volume":"61","author":"MA Schwarzbich","year":"2012","unstructured":"Schwarzbich, M. A. et al. The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR-ABL tyrosine kinase inhibitors. Cancer Immunol. Immunother. 61, 193\u2013202 (2012).","journal-title":"Cancer Immunol. Immunother."},{"key":"61931_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gene.2008.01.014","volume":"413","author":"VM Ripoll","year":"2008","unstructured":"Ripoll, V. M. et al. Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB. Gene. 413, 32\u201341 (2008).","journal-title":"Gene."},{"key":"61931_CR9","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1016\/j.yexcr.2008.02.006","volume":"314","author":"SM Abdelmagid","year":"2008","unstructured":"Abdelmagid, S. M. et al. Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function. Exp. Cell Res. 314, 2334\u20132351 (2008).","journal-title":"Exp. Cell Res."},{"key":"61931_CR10","doi-asserted-by":"publisher","first-page":"4320","DOI":"10.1182\/blood-2006-11-053769","volume":"109","author":"JS Chung","year":"2007","unstructured":"Chung, J. S., Sato, K., Dougherty, I. I., Cruz, P. D. Jr. & Ariizumi, K. DC-HIL is a negative regulator of T lymphocyte activation. Blood. 109, 4320\u20134327 (2007).","journal-title":"Blood."},{"key":"61931_CR11","doi-asserted-by":"publisher","first-page":"6557","DOI":"10.4049\/jimmunol.178.10.6557","volume":"178","author":"VM Ripoll","year":"2007","unstructured":"Ripoll, V. M., Irvine, K. M., Ravasi, T., Sweet, M. J. & Hume, D. A. Gpnmb is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses. J. Immunol. 178, 6557\u20136566 (2007).","journal-title":"J. Immunol."},{"key":"61931_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep00573","volume":"2","author":"H Tanaka","year":"2012","unstructured":"Tanaka, H. et al. The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis. Sci. Rep. 2, 573 (2012).","journal-title":"Sci. Rep."},{"key":"61931_CR13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/CMR.0b013e3283364a08","volume":"20","author":"MD Williams","year":"2010","unstructured":"Williams, M. D. et al. GPNMB expression in uveal melanoma: a potential for targeted therapy. Melanoma Res. 20, 184\u2013190 (2010).","journal-title":"Melanoma Res."},{"key":"61931_CR14","doi-asserted-by":"publisher","first-page":"15951","DOI":"10.1074\/jbc.M211498200","volume":"278","author":"JN Rich","year":"2003","unstructured":"Rich, J. N. et al. Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model. J. Biol. Chem. 278, 15951\u201315957 (2003).","journal-title":"J. Biol. Chem."},{"key":"61931_CR15","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1158\/1541-7786.MCR-07-0119","volume":"5","author":"AA Rose","year":"2007","unstructured":"Rose, A. A. et al. Osteoactivin promotes breast cancer metastasis to bone. Mol. Cancer Res. 5, 1001\u20131014 (2007).","journal-title":"Mol. Cancer Res."},{"key":"61931_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0168-8278(03)00361-1","volume":"39","author":"M Onaga","year":"2003","unstructured":"Onaga, M. et al. Osteoactivin expressed during cirrhosis development in rats fed a choline-deficient, L-amino acid-defined diet, accelerates motility of hepatoma cells. J. Hepatol. 39, 779\u2013785 (2003).","journal-title":"J. Hepatol."},{"key":"61931_CR17","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1158\/1078-0432.CCR-05-2018","volume":"12","author":"KF Tse","year":"2006","unstructured":"Tse, K. F. et al. CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma. Clin. Cancer Res. 12, 1373\u20131382 (2006).","journal-title":"Clin. Cancer Res."},{"key":"61931_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11828-3","volume":"7","author":"Y Noda","year":"2017","unstructured":"Noda, Y. et al. GPNMB induces BiP expression by enhancing splicing of BiP pre-mRNA during the endoplasmic reticulum stress response. Sci. Rep. 7, 12160 (2017).","journal-title":"Sci. Rep."},{"key":"61931_CR19","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1096\/fj.09-151019","volume":"24","author":"T Hoashi","year":"2010","unstructured":"Hoashi, T. et al. Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein. FASEB J. 24, 1616\u20131629 (2010).","journal-title":"FASEB J."},{"key":"61931_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep23241","volume":"6","author":"Y Ono","year":"2016","unstructured":"Ono, Y., Tsuruma, K., Takata, M., Shimazawa, M. & Hara, H. Glycoprotein nonmetastatic melanoma protein B extracellular fragment shows neuroprotective effects and activates the PI3K\/Akt and MEK\/ERK pathways via the Na+\/K+-ATPase. Sci. Rep. 6, 23241 (2016).","journal-title":"Sci. Rep."},{"key":"61931_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1100-1","volume":"15","author":"ML Neal","year":"2018","unstructured":"Neal, M. L., Boyle, A. M., Budge, K. M., Safadi, F. F. & Richardson, J. R. The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor. J. Neuroinflammation. 15, 73 (2018).","journal-title":"J. Neuroinflammation."},{"key":"61931_CR22","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1016\/j.jid.2018.05.012","volume":"138","author":"V Ramani","year":"2018","unstructured":"Ramani, V. et al. Melanoma-derived soluble DC-HIL\/GPNMB promotes metastasis by excluding T-lymphocytes from the pre-metastatic niches. J. Invest. Dermatol. 138, 2443\u20132451 (2018).","journal-title":"J. Invest. Dermatol."},{"key":"61931_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1755-148X.2008.00518.x","volume":"22","author":"SK Loftus","year":"2009","unstructured":"Loftus, S. K. et al. Gpnmb is a melanoblast-expressed, MITF-dependent gene. Pigment Cell Melanoma Res. 22, 99\u2013110 (2009).","journal-title":"Pigment Cell Melanoma Res."},{"key":"61931_CR24","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1021\/pr060363j","volume":"5","author":"A Chi","year":"2006","unstructured":"Chi, A. et al. Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. J. Proteome. Res. 5, 3155\u20133144 (2006).","journal-title":"J. Proteome. Res."},{"key":"61931_CR25","doi-asserted-by":"publisher","first-page":"e42955","DOI":"10.1371\/journal.pone.0042955","volume":"7","author":"P Zhang","year":"2012","unstructured":"Zhang, P. et al. Silencing of GPNMB by siRNA inhibits the formation of melanosomes in melanocytes in a MITF-independent fashion. PLoS One. 7, e42955 (2012).","journal-title":"PLoS One."},{"key":"61931_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ajhg.2017.12.012","volume":"102","author":"CF Yang","year":"2018","unstructured":"Yang, C. F. et al. Loss of GPNMB causes autosomal-recessive amyloidosis cutis dyschromica in humans. Am. J. Hum. Genet. 102, 219\u2013232 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"61931_CR27","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/jid.2015.25","volume":"135","author":"RY Wagner","year":"2015","unstructured":"Wagner, R. Y. et al. Altered E-cadherin levels and distribution in melanocytes precede clinical manifestations of vitiligo. J. Invest. Dermatol. 135, 1810\u20131819 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"61931_CR28","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.febslet.2008.03.030","volume":"582","author":"MH Sheng","year":"2008","unstructured":"Sheng, M. H., Wergedal, J. E., Mohan, S. & Lau, K. H. Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity. FEBS Lett. 582, 1451\u20131458 (2008).","journal-title":"FEBS Lett."},{"key":"61931_CR29","doi-asserted-by":"publisher","first-page":"e12093","DOI":"10.1371\/journal.pone.0012093","volume":"5","author":"AA Rose","year":"2010","unstructured":"Rose, A. A. et al. ADAM10 releases a soluble form of the GPNMB\/Osteoactivin extracellular domain with angiogenic properties. PLoS One. 5, e12093 (2010).","journal-title":"PLoS One."},{"key":"61931_CR30","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1073\/pnas.1304988111","volume":"111","author":"VT Natarajan","year":"2014","unstructured":"Natarajan, V. T. et al. IFN-\u03b3 signaling maintains skin pigmentation homeostasis through regulation of melanosome maturation. Proc. Natl. Acad. Sci. USA 111, 2301\u20132306 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61931_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09963-8","volume":"10","author":"MK Tulic","year":"2019","unstructured":"Tulic, M. K. et al. Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo. Nat. Commun. 10, 2178 (2019).","journal-title":"Nat. Commun."},{"key":"61931_CR32","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1038\/jid.2015.335","volume":"135","author":"C Regazzetti","year":"2015","unstructured":"Regazzetti, C. et al. Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway: a promising target for repigmenting vitiligo patients. J. Invest. Dermatol. 135, 3105\u20133114 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"61931_CR33","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","volume":"36","author":"DA Bassiouny","year":"2011","unstructured":"Bassiouny, D. A. & Shaker, O. Role of interleukin-17 in the pathogenesis of vitiligo. Clin. Exp. Dermatol. 36, 292\u2013297 (2011).","journal-title":"Clin. Exp. Dermatol."},{"key":"61931_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00403-016-1690-3","volume":"308","author":"Y Zhen","year":"2016","unstructured":"Zhen, Y. et al. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo. Arch. Dermatol. Res. 308, 703\u2013710 (2016).","journal-title":"Arch. Dermatol. Res."},{"key":"61931_CR35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.autrev.2016.01.004","volume":"15","author":"RK Singh","year":"2016","unstructured":"Singh, R. K. et al. The role of IL-17 in vitiligo: A review. Autoimmun. Rev. 15, 397\u2013404 (2016).","journal-title":"Autoimmun. Rev."},{"key":"61931_CR36","doi-asserted-by":"publisher","first-page":"4899","DOI":"10.1096\/fj.201701242RR","volume":"32","author":"J Zhou","year":"2018","unstructured":"Zhou, J. et al. IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo. FASEB J. 32, 4899\u20134916 (2018).","journal-title":"FASEB J."},{"key":"61931_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00008390-199602000-00005","volume":"6","author":"EH Danen","year":"1996","unstructured":"Danen, E. H., ten Berge, P. J., van Muijen, G. N., Jager, M. J. & Ruiter, D. J. Expression of CD44 and the pattern of CD44 alternative splicing in uveal melanoma. Melanoma Res. 6, 31\u201335 (1996).","journal-title":"Melanoma Res."},{"key":"61931_CR38","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/1523-1747.ep12348871","volume":"106","author":"KW Herbold","year":"1996","unstructured":"Herbold, K. W., Zhou, J., Haggerty, J. G. & Milstone, L. M. CD44 expression on epidermal melanocytes. J. Invest. Dermatol. 106, 1230\u20131235 (1996).","journal-title":"J. Invest. Dermatol."},{"key":"61931_CR39","doi-asserted-by":"publisher","first-page":"e102851","DOI":"10.1371\/journal.pone.0102851","volume":"9","author":"AE Booth","year":"2014","unstructured":"Booth, A. E., Tarafder, A. K., Hume, A. N., Recchi, C. & Seabra, M. C. A role for Na+, K+-ATPase \u03b11 in regulating Rab27a localisation on melanosomes. PLoS One. 9, e102851 (2014).","journal-title":"PLoS One."},{"key":"61931_CR40","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/jcb.25394","volume":"117","author":"B Yu","year":"2016","unstructured":"Yu, B., Sondag, G. R., Malcuit, C., Kim, M. H. & Safadi, F. F. Macrophage- associated osteoactivin\/GPNMB mediates mesenchymal stem cell survival, proliferation, and migration via a CD44-dependent mechanism. J. Cell. Biochem. 117, 1511\u20131521 (2016).","journal-title":"J. Cell. Biochem."},{"key":"61931_CR41","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/exd.13524","volume":"27","author":"WN Silva","year":"2018","unstructured":"Silva, W. N. et al. Macrophage-derived GPNMB accelerates skin healing. Exp. Dermatol. 27, 630\u2013635 (2018).","journal-title":"Exp. Dermatol."},{"key":"61931_CR42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jid.2017.08.034","volume":"138","author":"B Yu","year":"2018","unstructured":"Yu, B., Alboslemy, T., Safadi, F. & Kim, M. H. Glycoprotein Nonmelanoma Clone B Regulates the Crosstalk between Macrophages and Mesenchymal Stem Cells toward Wound Repair. J. Invest. Dermatol. 138, 219\u2013227 (2018).","journal-title":"J. Invest. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61931-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61931-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T03:47:12Z","timestamp":1670298432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-61931-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["61931"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-61931-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737590483.793572845","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"10 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Cosmetic Health Science Laboratory has been operated by a grant from Gifu City Hall, which is supported by Ichimaru Pharcos Co. Ltd, Gifu, Japan. The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4930"}}